04:28 AM EDT, 03/20/2026 (MT Newswires) -- Stephen Michael Kelsey, President of Research and Development, on March 17, 2026, sold 4,302 shares in Revolution Medicines ( RVMD ) for $427,965. Following the Form 4 filing with the SEC, Kelsey has control over a total of 295,398 common shares of the company, with 295,398 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1628171/000161071726000131/xslF345X05/form4.xml ...

04:29 AM EDT, 03/20/2026 (MT Newswires) -- Mark A Goldsmith, Director, President and Chief Executive Officer, on March 17, 2026, sold 12,871 shares in Revolution Medicines ( RVMD ) for $1,280,412. Following the Form 4 filing with the SEC, Goldsmith has control over a total of 999,606 common shares of the company, with 276,698 shares held directly and 722,908 controlled...

04:30 AM EDT, 03/20/2026 (MT Newswires) -- Margaret A Horn, Chief Operating Officer, on March 17, 2026, sold 4,583 shares in Revolution Medicines ( RVMD ) for $455,919. Following the Form 4 filing with the SEC, Horn has control over a total of 157,570 common shares of the company, with 157,570 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1628171/000161071726000129/xslF345X05/form4.xml ...

03:42 AM EDT, 03/20/2026 (MT Newswires) -- Guardian Metal Resources ( GMTL ) said late Thursday it priced its upsized $60 million initial public offering in the US. The exploration stage company is issuing 4.4 million American depositary shares, representing 22.2 million ordinary shares, at a price of $13.50 per ADS. Guardian Metal has granted underwriters a 45-day option to...